Prevalence of Depressive Symptoms and Associated Factors among HIV-Positive Youth Attending ART Follow-Up in Addis Ababa, Ethiopia
Prevalence of Depressive Symptoms and Associated Factors among HIV-Positive Youth Attending ART Follow-Up in Addis Ababa, Ethiopia
复制标题
DOI：
10.1155/2019/4610458
复制
发表时间：
2019-01-01
影响因子：
1.7
通讯作者：
Abebaw, Dessie
中科院分区：
文献类型：
--
作者：
Abebe, Helina;Shumet, Shegaye;Abebaw, Dessie
抑郁症是艾滋病毒/艾滋病患者尤其是感染艾滋病毒/艾滋病的青少年中最常见、最常见的精神障碍。本研究旨在评估在埃塞俄比亚亚的斯亚贝巴公立医院接受抗逆转录病毒治疗 (ART) 随访的人类免疫缺陷病毒 (HIV) 青少年中抑郁症状的患病率和相关因素。客观的。旨在评估 2016 年埃塞俄比亚亚的斯亚贝巴公立医院接受抗逆转录病毒治疗 (ART) 随访的人类免疫缺陷病毒 (HIV) 青少年抑郁症状的患病率和相关因素。方法。在一项横断面研究中，通过系统随机抽样技术招募了来自公共卫生医院的 507 名艾滋病毒呈阳性的年轻人。 Beck抑郁量表-II用于评估抑郁症状。 Morisky 药物依从性评定量表、社会支持评定量表和 HIV 耻辱量表是用于评估相关因素的工具。结果。 HIV 阳性青少年中抑郁症状的患病率为 35.5% (95% CI:31.3, 39.6)。多变量分析中，年龄范围在 20 至 24 岁之间（AOR=2.22，95% CI：1.33,3.62），有机会性感染史（AOR=1.94，95% CI：1.15,3.27），用药依从性差（AOR=1.73，95% CI：1.13,2.64），社会支持低（AOR=2.74，95%CI：1.13，2.64）、中等社会支持（AOR=1.75，95%CI：1.03，2.98）和耻辱感（AOR=2.06，95%CI：1.35，3.14）与抑郁症状相关。对于艾滋病毒呈阳性的青少年来说，耻辱感和良好服药依从性的咨询是必要的。
Depression is most frequently and highly occurring common mental disorder in HIV/AIDS patients especially youth living with HIV/AIDS. This study aimed to assess the prevalence and associated factors of depressive symptoms among youth living with Human Immunodeficiency Virus (HIV) attending Antiretroviral Therapy (ART) follow-up at public hospitals in Addis Ababa, Ethiopia. Objective. To assess the prevalence and associated factors of depressive symptoms among youth living with Human Immunodeficiency Virus (HIV) attending Antiretroviral Therapy (ART) follow-up at public hospitals Addis Ababa, Ethiopia, 2016. Method. In a cross sectional study, 507 HIV-positive young people from public health hospitals were recruited by systematic random sampling technique. Beck Depression Inventory-II was used to assess depressive symptoms. Morisky medication adherence rating scale, social support rating scale, and HIV stigma scale were the instruments used to assess the associated factors. Results. Prevalence of depressive symptoms among HIV-positive youth was 35.5% (95% CI:31.3, 39.6). In multivariate analysis, age range between 20 and 24 years with (AOR=2.22, 95% CI: 1.33,3.62), history of opportunistic infection (AOR=1.94, 95% CI:1.15,3.27), poor medication adherence (AOR=1.73, 95%CI:1.13,2.64, low social support (AOR=2.74, 95%CI:1.13,2.64), moderate social support (AOR=1.75 95% CI: 1.03,2.98), and stigma (AOR=2.06, 95% CI: 1.35,3.14) were associated with depressive symptoms. The results suggest that prevalence of depressive symptoms among HIV-positive youth was high. Prevention of opportunistic infection, stigma, and counseling for good medication adherence are necessary among HIV-positive youth.